Allstate Corporation’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Buy
19,792
+123
+0.6% +$2.63K ﹤0.01% 1145
2026
Q1
$398K Buy
+19,669
New +$437K ﹤0.01% 1041

Other funds holding ADNT

Allstate Corporation's ADNT Position: Q2 2026 in Review

Allstate Corporation increased its Adient (ADNT) stake by 0.63% in Q2 2026, buying an estimated $2.63K and bringing the position to 19,792 shares worth $364K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Allstate Corporation first reported a position in ADNT in Q1 2026 and has held it in 2 quarters since. The position peaked at $398K in Q1 2026. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Allstate Corporation held 19,792 shares of Adient worth $364K as of Q2 2026.
  • Allstate Corporation bought 123 Adient shares in Q2 2026, an estimated $2.63K.
  • Adient made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1145 holding.
  • Allstate Corporation first reported a position in Adient in Q1 2026 and has held it in 2 quarters since.
  • Allstate Corporation's Adient position peaked at $398K in Q1 2026.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.